Evidence map›Paper›PMID 33803877›Full record

ArticleMolecules (Basel, Switzerland)2021

5-Aryl-1-Arylideneamino-1

Ali H Abu Almaaty, Eslam E M Toson, El-Sherbiny H El-Sayed, Mohamed A M Tantawy, Eman Fayad, Ola A Abu Ali, Islam Zaki

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. The crystal structure of tetra-kis-(5-phenyl-1Acta crystallographica. Section E, Crystallographic communications · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Chemotherapeutic Activities of New ηMolecules (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Evaluation of Synthetic 2,4-Disubstituted-benzo[Pharmaceuticals (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ali H Abu AlmaatyZoology Department, Faculty of Science, Port Said University, Port Said 42526, Egypt.ORCID 0000-0001-9056-0228
Eslam E M TosonChemistry Department, Faculty of Science, Port Said University, Port Said 42526, Egypt.
El-Sherbiny H El-SayedChemistry Department, Faculty of Science, Port Said University, Port Said 42526, Egypt.
Mohamed A M TantawyMedical Research Division, National Research Centre, Dokki, Giza 12511, Egypt.
Eman FayadBiotechnology Department, Faculty of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0003-2916-0254
Ola A Abu AliChemistry Department, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Islam ZakiPharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt.ORCID 0000-0002-2026-7373
Port Said University · EGTaif University · SANational Research Centre · EG

Funding

Taif University Researchers Supporting Project number (TURSP-2020/220), Taif University, Taif, Saudi Arabia
6 · The paper itself

Abstract

A novel series of

Indexed as

Antineoplastic AgentsApoptosisCell SurvivalDrug Screening Assays, AntitumorErlotinib HydrochlorideG2 Phase Cell Cycle CheckpointsHCT116 CellsHep G2 CellsHumansImidazolesIn Vitro TechniquesMCF-7 CellsMolecular Docking SimulationProto-Oncogene Proteins B-rafStructure-Activity RelationshipThionesAntineoplastic AgentsBRAF protein, humanErlotinib HydrochlorideImidazolesKDR protein, humanProto-Oncogene Proteins B-rafThionesVascular Endothelial Growth Factor Receptor-2Annexin Vapoptosiscell cycle analysiscytotoxicityimidazolesynthesisVEGFR-2

Identifiers

PMID33803877
PMCPMC8003321
OpenAlexW3139079066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.